TREX Trademark

Trademark Overview

On Friday, April 17, 2026, a trademark application was filed for TREX with the United States Patent and Trademark Office. The USPTO has given the TREX trademark a serial number of 99771878. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, April 17, 2026. This trademark is owned by Glaukos Corporation. The TREX trademark is filed in the Medical Instrument Products category with the following description:

Intraocular drug delivery system comprising intraocular ophthalmic synthetic implants, namely, micro-stents, for use in the treatment of diseases of the eye
trex

General Information

Serial Number99771878
Word MarkTREX
Filing DateFriday, April 17, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, April 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkTYRANNOSAURUS REX
Goods and Services Intraocular drug delivery system comprising intraocular ophthalmic synthetic implants, namely, micro-stents, for use in the treatment of diseases of the eye
Pseudo MarkT REX

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 17, 2026
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaukos Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAliso Viejo, CA 92656
US

Trademark Events

Event DateEvent Description
Friday, April 17, 2026NEW APPLICATION ENTERED
Friday, April 17, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

trex intraocular namely micro stents diseases treatment implants synthetic drug delivery